Brusilow WS - Search Results

1

Amino acids as biomarkers in the SOD1(G93A) mouse model of ALS.

Bame M, Grier RE, Needleman R, Brusilow WS. Bame M, et al. Among authors: brusilow ws. Biochim Biophys Acta. 2014 Jan;1842(1):79-87. doi: 10.1016/j.bbadis.2013.10.004. Epub 2013 Oct 12. Biochim Biophys Acta. 2014. PMID: 24129262 Free article.

2

Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS.

Ghoddoussi F, Galloway MP, Jambekar A, Bame M, Needleman R, Brusilow WS. Ghoddoussi F, et al. Among authors: brusilow ws. J Neurol Sci. 2010 Mar 15;290(1-2):41-7. doi: 10.1016/j.jns.2009.11.013. Epub 2010 Jan 8. J Neurol Sci. 2010. PMID: 20060132

3

Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS.

Bame M, Pentiak PA, Needleman R, Brusilow WS. Bame M, et al. Among authors: brusilow ws. Gend Med. 2012 Dec;9(6):524-35. doi: 10.1016/j.genm.2012.10.014. Gend Med. 2012. PMID: 23217569

4

A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure.

Jambekar AA, Palma E, Nicolosi L, Rasola A, Petronilli V, Chiara F, Bernardi P, Needleman R, Brusilow WS. Jambekar AA, et al. Among authors: brusilow ws. Liver Int. 2011 Sep;31(8):1209-21. doi: 10.1111/j.1478-3231.2011.02553.x. Epub 2011 May 31. Liver Int. 2011. PMID: 21745296

5

Immunosuppressant-like effects of phenylbutyrate on growth inhibition of Saccharomyces cerevisiae.

Grzanowski A, Needleman R, Brusilow WS. Grzanowski A, et al. Among authors: brusilow ws. Curr Genet. 2002 Jun;41(3):142-9. doi: 10.1007/s00294-002-0292-0. Epub 2002 May 8. Curr Genet. 2002. PMID: 12111095

6

Activity of the yeast Tat2p tryptophan permease is sensitive to the anti-tumor agent 4-phenylbutyrate.

Liu M, Brusilow WS, Needleman R. Liu M, et al. Among authors: brusilow ws. Curr Genet. 2004 Nov;46(5):256-68. doi: 10.1007/s00294-004-0531-7. Curr Genet. 2004. PMID: 15490173

7

Identification of the isomer of methionine sulfoximine that extends the lifespan of the SOD1 G93A mouse.

Brusilow WS. Brusilow WS. Neurosci Lett. 2017 Apr 24;647:165-167. doi: 10.1016/j.neulet.2017.03.029. Epub 2017 Mar 18. Neurosci Lett. 2017. PMID: 28323087

8

Therapeutic effects of methionine sulfoximine in multiple diseases include and extend beyond inhibition of glutamine synthetase.

Brusilow WS, Peters TJ. Brusilow WS, et al. Expert Opin Ther Targets. 2017 May;21(5):461-469. doi: 10.1080/14728222.2017.1303484. Epub 2017 Mar 15. Expert Opin Ther Targets. 2017. PMID: 28292200 Review.

9

Effects of deletions in the uncA-uncG intergenic regions on expression of uncG, the gene for the gamma subunit of the Escherichia coli F1Fo-ATPase.

Angov E, Brusilow WS. Angov E, et al. Among authors: brusilow ws. Biochim Biophys Acta. 1994 Jan 4;1183(3):499-503. doi: 10.1016/0005-2728(94)90077-9. Biochim Biophys Acta. 1994. PMID: 8286398

10

In vitro suppression of inflammatory cytokine response by methionine sulfoximine.

Peters TJ, Jambekar AA, Brusilow WSA. Peters TJ, et al. Among authors: brusilow wsa. J Inflamm (Lond). 2018 Sep 10;15:17. doi: 10.1186/s12950-018-0193-8. eCollection 2018. J Inflamm (Lond). 2018. PMID: 30214381 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters